News | Heart Failure | November 21, 2022

Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology

Cardiovascular disease remains the leading cause of death in the United States (US) and worldwide, according to the American Heart Association.

November 21, 2022 — Cardiovascular disease remains the leading cause of death in the United States (US) and worldwide, according to the American Heart Association. With risk factors for cardiovascular disease such as obesity and type 2 diabetes on the rise in the US, the field of cardiovascular medicine finds itself in need of a paradigm shift to improve the cardiovascular health of our nation. 

In a concerted effort to move the needle, clinicians specializing in the prevention of cardiovascular disease, along with the American Society for Preventive Cardiology (ASPC), are rapidly growing the subspecialty referred to commonly as "preventive cardiology". 

 "The importance of cardiovascular disease prevention has never been more urgent for the United States and the world." shares President of the ASPC, Dr. Martha Gulati. "Changing our focus from 'sick care' to true 'health care' starts with cardiovascular disease prevention, and this will be led by preventive cardiologists. This important statement from ASPC should serve as a guide to our cardiology community towards an approach to improve the heart health of our patients." 

Recently published in the American Journal of Preventive Cardiology, this clinical practice statement endorsed by the ASPC delineates the key attributes that define the field of preventive cardiology. Lead author, Charles German, MD shares the importance of this publication: "Despite concerted efforts, high rates of cardiovascular diseases continue to plague our society. Preventive cardiologists are needed now more than ever to help improve the cardiovascular health of our population, and we hope this statement helps bring clarity and unity to the field." 

For more information: https://www.sciencedirect.com/science/article/pii/S2666667722001167  


Related Content

News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions ...

Home March 15, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc., a biotechnology company focused on advancing late-stage cell therapy interventions for ...

Home March 15, 2024
Home
News | Heart Failure

March 13, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2024
Home
News | Heart Failure

March 8, 2024 — The Texas Heart Institute, Georgia Institute of Technology (Georgia Tech), North Carolina State ...

Home March 08, 2024
Home
News | Heart Failure

March 5, 2024 — FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2 ...

Home March 05, 2024
Home
Subscribe Now